GGGGX | RGVCX | GGGGX / RGVCX | |
Total Expense Ratio | 0.83 | 0.89 | 93% |
Annual Report Gross Expense Ratio | 0.86 | 0.93 | 92% |
Fund Existence | 17 years | 23 years | - |
Gain YTD | 7.946 | 7.172 | 111% |
Front Load | 3% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 691M | 23.8B | 3% |
Annual Yield % from dividends | 3.88 | 3.76 | 103% |
Returns for 1 year | 5.99 | 5.10 | 118% |
Returns for 3 years | 17.45 | 12.93 | 135% |
Returns for 5 years | -0.93 | -6.65 | 14% |
Returns for 10 years | 9.87 | 3.50 | 282% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TLCI | 26.37 | 0.02 | +0.07% |
Touchstone International Equity ETF | |||
RYSE | 22.66 | N/A | N/A |
Cboe Vest 10 Yr Intst Rt Hdg ETF | |||
PPH | 91.80 | -0.33 | -0.36% |
VanEck Pharmaceutical ETF | |||
WLTG | 34.92 | -0.20 | -0.57% |
WealthTrust DBS Long Term Growth ETF | |||
RFV | 125.15 | -1.22 | -0.97% |
Invesco S&P MidCap 400® Pure Value ETF |